bibliographicCitation |
Gradman AH, Schmieder RE, Lins RL, Nussberger J, Chiang Y, Bedigian MP. Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients. Circulation. 2005 Mar 01;111(8):1012–8. doi: 10.1161/01.cir.0000156466.02908.ed. PMID: 15723979. |